Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial
2025 · The Lancet Oncology · 11 citations
https://doi.org/10.1016/s1470-2045(25)00213-x
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
442
Citations
10
h-index
10
i10-index
Lindy Berkman is an academic researcher. The author has contributed to research in topics: Colorectal and Anal Carcinomas & Colorectal Cancer Screening and Detection & Gastric Cancer Management and Outcomes. The author has an h-index of 10, co-authored 21 publications.
https://doi.org/10.1016/s1470-2045(25)00213-x
https://doi.org/10.1016/j.clon.2017.02.014
Click to start Chat